Serum concentrations of natalizumab, endogenous IGG4, and SVCAM-1 in natalizumab-treated PML patients

Authors
Category Primary study
JournalNeurology
Year 2013
This article has no abstract
Epistemonikos ID: 4cccb2895eb5d32cf6408286c18e5e84c29c54cd
First added on: Feb 05, 2025